EPREX STERILE SOLUTION Canada - English - Health Canada

eprex sterile solution

janssen inc - epoetin alfa - solution - 30000unit - epoetin alfa 30000unit - hematopoietic agents

Lunava Australia - English - Department of Health (Therapeutic Goods Administration)

lunava

medis pharma pty ltd - leflunomide -

Roferon-A Australia - English - Department of Health (Therapeutic Goods Administration)

roferon-a

roche products pty ltd - interferon alfa-2a -

Leflunomide 10 mg Film Coated Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

leflunomide 10 mg film coated tablets

morningside healthcare limited - leflunomide - tablet - 10 milligram(s) - selective immunosuppressants; leflunomide

Leflunomide 20mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

leflunomide 20mg film-coated tablets

aspire pharma limited - leflunomide - film-coated tablet - 20 milligram(s) - selective immunosuppressants; leflunomide

Leflunomide 20 mg Film Coated Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

leflunomide 20 mg film coated tablets

morningside healthcare limited - leflunomide - tablet - 20 milligram(s) - selective immunosuppressants; leflunomide

Leflunomide 100 mg Film Coated Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

leflunomide 100 mg film coated tablets

morningside healthcare limited - leflunomide - tablet - 100 milligram(s) - selective immunosuppressants; leflunomide

Leflunomide 10 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

leflunomide 10 mg film-coated tablets

aspire pharma limited - leflunomide - film-coated tablet - 10 milligram(s) - selective immunosuppressants; leflunomide

Repso European Union - English - EMA (European Medicines Agency)

repso

teva b.v. - leflunomide - arthritis, rheumatoid; arthritis, psoriatic - immunosuppressants - leflunomide is indicated for the treatment of adult patients with:active rheumatoid arthritis as a ‘disease-modifying antirheumatic drug’ (dmard);active psoriatic arthritis.recent or concurrent treatment with hepatotoxic or haematotoxic dmards (e.g. methotrexate) may result in an increased risk of serious adverse reactions; therefore, the initiation of leflunomide treatment has to be carefully considered regarding these benefit / risk aspects.moreover, switching from leflunomide to another dmard without following the washout procedure may also increase the risk of serious adverse reactions even for a long time after the switching.

ROFERON-A interferon alfa-2a 9 million IU/0.5mL injection pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

roferon-a interferon alfa-2a 9 million iu/0.5ml injection pre-filled syringe

roche products pty ltd - interferon alfa-2a -